Ann: PharmAust to Evaluate Monepantel on COVID-19, page-38

Quote

PharmAust Executive Chairman Dr Roger Aston said "This is an important project".

"We are delighted to be working with the Walter and Eliza Hall Institute of Medical Research on this timely and important project and delighted that Professor Marc Pellegrini has agreed to be the Investigator,"

and from Doctor Mollard

"Shareholders won't have to wait long to get a feel for how monepantel performs against COVID-19, either". PharmAust Chief Scientific Officer Dr Richard Mollard said preliminary data from the studies will be available as early as May 2020.

Very short term ,, Catalyst Event with in the next 50 days ,,, near term rewards in this game... Next week will attract some wider market attention..